Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature by Matthew Biggerstaff et al.
RESEARCH ARTICLE Open Access
Estimates of the reproduction number for
seasonal, pandemic, and zoonotic influenza: a
systematic review of the literature
Matthew Biggerstaff1*, Simon Cauchemez2, Carrie Reed1, Manoj Gambhir3 and Lyn Finelli1
Abstract
Background: The potential impact of an influenza pandemic can be assessed by calculating a set of transmissibility
parameters, the most important being the reproduction number (R), which is defined as the average number of
secondary cases generated per typical infectious case.
Methods: We conducted a systematic review to summarize published estimates of R for pandemic or seasonal
influenza and for novel influenza viruses (e.g. H5N1). We retained and summarized papers that estimated R for
pandemic or seasonal influenza or for human infections with novel influenza viruses.
Results: The search yielded 567 papers. Ninety-one papers were retained, and an additional twenty papers
were identified from the references of the retained papers. Twenty-four studies reported 51 R values for the
1918 pandemic. The median R value for 1918 was 1.80 (interquartile range [IQR]: 1.47–2.27). Six studies
reported seven 1957 pandemic R values. The median R value for 1957 was 1.65 (IQR: 1.53–1.70). Four studies
reported seven 1968 pandemic R values. The median R value for 1968 was 1.80 (IQR: 1.56–1.85). Fifty-seven
studies reported 78 2009 pandemic R values. The median R value for 2009 was 1.46 (IQR: 1.30–1.70) and was
similar across the two waves of illness: 1.46 for the first wave and 1.48 for the second wave. Twenty-four
studies reported 47 seasonal epidemic R values. The median R value for seasonal influenza was 1.28 (IQR:
1.19–1.37). Four studies reported six novel influenza R values. Four out of six R values were <1.
Conclusions: These R values represent the difference between epidemics that are controllable and cause
moderate illness and those causing a significant number of illnesses and requiring intensive mitigation
strategies to control. Continued monitoring of R during seasonal and novel influenza outbreaks is needed to
document its variation before the next pandemic.
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Background
Annual influenza epidemics occur worldwide and cause
substantial morbidity and mortality [1]. In the United
States between 5% and 20% of the population are in-
fected with influenza every year [2], resulting in between
3,000 and 49,000 influenza-associated deaths [3]. Influ-
enza viruses are constantly changing either through the
collection of minor point mutations or through major
antigenic shifts. These major shifts can result in the
introduction of novel influenza viruses into the human
population to which humans have little or no immunity,
causing pandemics [1]. Four influenza pandemics have
occurred since the beginning of the 20th century and
have ranged widely in transmissibility and clinical
severity [1,4].
Recognizing that the characteristics of future pande-
mics will be difficult to predict given the mutability of the
influenza virus and the range of morbidity and mortality
experienced in previous pandemics, an approach to the
early assessment of influenza pandemics has been deve-
loped relying on standardized measures of transmissibi-
lity and clinical severity [5]. An important transmissibility
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parameter identified is the reproduction number (R),
which is defined as the average number of secondary cases
generated per typical infectious case [6,7]. R describes on
average how many persons a case will infect, and a value
of R greater than 1 indicates that the infection may grow
or persist in the population while a value of R less than 1
indicates that the infection will decline in the population,
although exceptions exist [7,8]. Many methods to calculate
R have been described that allow for the use of epidemio-
logic data from different epidemic time points [7]. Some
examples include estimating R using the growth rate of
the epidemic, the epidemic curve’s size and shape, the
final attack rate, or by direct observation of disease trans-
mission from one generation to the next [7]. The popula-
tion susceptibility to the infection also affects the
interpretation of R. If R is calculated in a population en-
tirely susceptible to infection (or where an assumption
about population susceptibility to infection is made), then
R is known as the basic reproduction number (R0). In con-
trast, the effective reproduction number (RE) is calculated
in a population with underlying immunity and accounts
for a population’s reduced susceptibility to infection [9].
The value of R characterizes the final number infected
in the absence of an intervention in homogeneously
mixed populations, the herd immunity threshold, and,
when coupled with the generation time, defined as the
interval between infections in two consecutive genera-
tions, or the serial interval, defined as the interval be-
tween the onset of symptoms in two consecutive
generations), the speed with which the disease spreads
in the population [10-12]. Therefore, the magnitude of R
plays an important role in the selection and aggressive-
ness of countermeasures (e.g. social distancing, treating
ill individuals, or vaccination) required to slow transmis-
sion of the disease [10,13].
Because R is used as a measure of transmissibility and
informs the selection of different mitigation strategies, it
is important to understand the range and uncertainty of
published R values. In this paper, we investigate whether
published estimates of R differ between pandemic, sea-
sonal, and novel influenza, we compare values of R cal-
culated in differing geographic regions and settings, and
we explore the assumptions and limitations of the esti-
mation methods of R.
Methods
We performed a literature search using the PubMed
database from 1950 to January 16, 2013. The following
key terms were searched: “reproduction number and in-
fluenza”, “reproductive number and influenza”, “R0 and
influenza”, “reproduction rate and influenza”, and “re-
productive rate and influenza”. We limited our search to
articles in English. We retained articles that estimated R
for pandemic or seasonal influenza or for human
infections with non-human influenza viruses (e.g. H5N1).
For all studies retained, we abstracted the date of pub-
lication, the year, the geographic location where the data
were collected, the influenza subtype, the study popu-
lation, whether it was a confined setting, the wave of the
observation (if during a pandemic), the estimated value
of R, the method to identify influenza cases, and whe-
ther it was a R0 or RE. If multiple R values were provi-
ded, we provide the median and range. Since methods
to estimate the reproduction number often require a
value for the generation time or the serial interval, we
also report those values [14]. We classified the method
used to determine influenza-associated cases into two
categories: laboratory confirmed, which required the use
of confirmatory testing of respiratory or blood specimens,
or unconfirmed, which relied on syndromic case defini-
tions to identify cases and required no laboratory con-
firmation of illnesses.
Median R values and interquartile ranges (IQR) were
reported for each pandemic and for the group of inter-
pandemic seasonal epidemics. If a range of values was
given for an individual study instead of a point estimate,
the middle value of the range was used in the pandemic
or epidemic median calculations.
Results
The search strategy initially identified 567 papers
(Figure 1). Ninety-one papers were retained that esti-
mated R for pandemic or seasonal influenza or for human
infections with non-human influenza viruses (e.g. H5N1).
Twenty additional papers were contributed by the
references of the papers identified through the original
search. In all, 111 articles were retained that presented ori-
ginal estimates of the reproduction number (summarized
in Tables 1, 2, 3, 4, 5 and 6). Data provided in the tables
are also available as .csv files in Additional files 1, 2, 3, 4, 5
and 6.
1918 influenza pandemic
The origins of the 1918 influenza A/H1N1 pandemic are
unknown, and illnesses are thought to have occurred in
three waves [1,37]. The first wave began in the Northern
Hemisphere in the spring 1918 [1]. A second wave of
more intense transmission occurred concurrently in
North America, Europe, and Africa in fall 1918, and a
third and final wave occurred in some areas of the world
during winter 1919 [37,125]. The 1918 pandemic was
the most deadly pandemic ever recorded, and an esti-
mated 675,000 deaths occurred in the United States dur-
ing the pandemic period. In contrast to seasonal
influenza, which disproportionately affects the very
young and old, those aged 20–40 years were especially
affected [37].
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Twenty-four studies reported 51 separate 1918 pan-
demic values of R (Table 1; Figure 2). The median point
estimate of R in the community setting for all waves of
illness was 1.80 (IQR: 1.47–2.27) (Table 1). A higher me-
dian R value (R = 3.82; IQR: 2.68–4.84) was reported in
confined settings, such as ships, military camps, and
schools. The median values of R were similar between
the first and subsequent waves of illness: the median
value of R was 1.81 (IQR: 1.50–2.28) for the 1st wave,
1.73 (IQR: 1.39–2.33) for the second wave, and 1.70
(IQR: 1.55–1.76) for the third wave (Table 1).
The majority of 1918 pandemic values for R were cal-
culated for populations in Europe, which accounted for
58% of the R estimates included in this analysis. The
mean generation time or serial interval used in the cal-
culations to estimate R had a median value of 3.3 days,
and the mean ranged from 1.5–6 days. Because the in-
fluenza virus was not discovered until 1931[1], all studies
included in this review relied on reports of uncon-
firmed illness to identify those ill. A majority (65%) used
pneumonia-and-influenza-related hospitalizations and
deaths as the case ascertainment source (Table 1).
1957 influenza pandemic
The 1957 influenza A/H2N2 pandemic began in Febru-
ary 1957 in southern China and spread to Singapore and
Hong Kong in April [1]. The virus was first isolated in
the United States in June 1957 and was associated with a
first wave [1,41]. The peak of the pandemic occurred
during the second wave in the Northern Hemisphere in
October 1957 and was followed by a third wave in Janu-
ary 1958. An estimated 115,000 deaths occurred in the
United States during the pandemic period [37].
Six studies reported seven separate 1957 pandemic
values of R (Table 2; Figure 3). The median point esti-
mate of R in the community setting for the second wave
of illnesses was 1.65 (IQR: 1.53–1.70). No R values were
reported for confined settings or for the 1st or 3rd waves
of illness.
A majority (86%) of 1957 pandemic R values were cal-
culated for populations in Europe. The mean generation
time or serial interval used in the calculations to deter-
mine R had a median value of 3.5 days, and the mean
ranged from 2.6–4.1 days. All studies but one included
in this review relied on an unconfirmed illnesses to iden-
tify those ill. The other study relied on the final attack
rate as determined by serological methods (Table 2).
1968 influenza pandemic
The 1968 influenza A/H3N2 pandemic began in Hong
Kong in July 1968. Large single waves were reported in
the Northern Hemisphere between September 1968 and
April 1969 (with peaks occurring in December and Janu-
ary) and in the Southern Hemisphere between June and
September 1969. Some countries in the Northern Hemi-
sphere, such as the United Kingdom, did not have an
Figure 1 PRISMA flowchart of the article selection for the reproductive number and influenza literature review.
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95% CIc Basic or
effective
Case definition Reference Year
published
Australia 1st Community 2.6 1.80 1.6–2.0 Basic Unconfirmed
hospitalizations/deaths
[15] 2008
Brazil 1st Community 4 2.68 Basic Unconfirmed illness [16] 2007
Canada 1st Community 3 1.50 1.5–1.5 Basic Unconfirmed deaths [17] 2011
Canada 1st Community 6 2.1 2.1–2.1 Basic Unconfirmed deaths [17] 2011
Colombia 1st Community 3 1.4–1.5 Effective Unconfirmed deaths [18] 2012
Colombia 1st Community 4 1.5–1.7 Effective Unconfirmed deaths [18] 2012
Denmark 1st Community 2.6 2.2–2.4 Effective Unconfirmed illness [19] 2008
Denmark 1st Community 4 2.8–3.0 Effective Unconfirmed illness [19] 2008
Denmark 1st Community 2.6 2.8–4.0 Effective Unconfirmed
hospitalizations
[19] 2008
Denmark 1st Community 4 3.6–5.4 Effective Unconfirmed
hospitalizations
[19] 2008
Italy 1st Community 3 1.03 1.00–1.08 Basic Unconfirmed
hospitalizations
[20] 2011
Mexico 1st Community 3 1.30 Effective Unconfirmed deaths [21] 2010
Peru 1st Community 3 1.38 1.37–1.40 Effective Unconfirmed deaths [22] 2011
Switzerland 1st Community 3.11 1.49 1.45–1.53 Basic Unconfirmed
hospitalizations
[23] 2006
Switzerland 1st Community 3.4 1.50 Basic Unconfirmed deaths [24] 2009
United
Kingdom
1st Community 2.6 1.7 Basic Unconfirmed deaths [10] 2006
United
Kingdom
1st Community 4.1 2.10 Effective Unconfirmed illness [25] 2006
United
Kingdom
1st Community 6 2.00 Basic Unconfirmed illness [26] 2005
United
Kingdom
1st Community NR 1.16–2.94 Effective Unconfirmed illness [27] 2010
United
Kingdom
1st Students NR 1.43–5.36 Effective Unconfirmed illness [27] 2010
USA 1st Community 4 1.34–3.21 Effective Unconfirmed illness [28] 2008
Various 1st Community 4 1.2–3.0 Effective Unconfirmed illness [29] 2007
Various 1st Community 4 2.1–7.5 Effective Unconfirmed illness [29] 2007
1st Sailors 4 4.97 Effective Unconfirmed illness [28] 2008
Canada 2nd Community 3.6 2.26 1.95–2.63 Basic Unconfirmed illness [30] 2010
Canada 2nd Community 3.6 1.49 1.42–1.55 Basic Unconfirmed illness [30] 2010
Canada 2nd Community 3 2.40 2.4–2.5 Basic Unconfirmed deaths [17] 2011
Canada 2nd Community 6 4.3 4.2–4.4 Basic Unconfirmed deaths [17] 2011
Denmark 2nd Community 2.6 1.22–1.24 Effective Unconfirmed illness [19] 2008
Denmark 2nd Community 4 1.29–1.33 Effective Unconfirmed illness [19] 2008
Denmark 2nd Community 2.6 1.2–1.3 Effective Unconfirmed
hospitalizations
[19] 2008
Denmark 2nd Community 4 1.3–1.4 Effective Unconfirmed
hospitalizations
[19] 2008
Germany 2nd Community 1 1.58 0.03–10.3 Basic Unconfirmed deaths [31] 2007
Germany 2nd Community 3 2.52 0.75–5.85 Basic Unconfirmed deaths [31] 2007
Germany 2nd Community 5 3.41 1.91–5.57 Basic Unconfirmed deaths [31] 2007
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outbreak of H3N2 until the winter of 1969–70. In all, an
estimated 110,000 deaths occurred in the United States
during the pandemic period [37].
Four studies reported seven separate 1968 pandemic
values of R (Table 3; Figure 3). The median point esti-
mate of R in the community setting for all waves of ill-
ness was 1.80 (IQR: 1.56–1.85) (Table 3). Only two
values for R in confined settings were reported, and the
median value was 1.39. Two values of R were reported
in a community setting during the first wave and three
during the second wave. The median value of R during
the 1st wave was 1.56 and 1.68 during the 2nd wave
(Table 3).
The 1968 pandemic values for R were calculated
among populations in diverse geographic locations,
mainly because of one study that calculated separate
values for over 25 locations, such as Africa, Asia, and
South America (the overall estimate for R is included in
Table 3) [43]. The mean generation time or serial in-
terval used in the calculations to determine R had a me-
dian value of 4 days with little variation. The studies for
the 1968 pandemic included in this review relied on a
mix of laboratory-confirmed, unconfirmed illnesses, or
serologically-confirmed infections to identify those ill
(Table 3).
The 2009 influenza pandemic
The 2009 influenza A/H1N1 pandemic began in Mexico
in the late winter or early spring 2009 [44]. The United
States and the United Kingdom experienced a first wave
of illnesses in the spring followed by a second wave dur-
ing the fall [4]. However, a number of other countries,
especially in the Southern Hemisphere, only experienced
a single wave of illnesses [100]. In all, an estimated
12,000 deaths occurred in the United States during the
first year of pandemic circulation [126].
Table 1 Reproduction numbers from the 1918 Influenza A/H1N1 Pandemic (Continued)
Italy 2nd Community 3 1.38 1.3–1.5 Basic Unconfirmed
hospitalizations
[20] 2011
Mexico 2nd Community 3 1.30 Effective Unconfirmed deaths [21] 2010
New
Zealand
2nd Military >1.5 1.3–3.1 Basic Unconfirmed
hospitalizations
[32] 2006
Switzerland 2nd Community 2.28 3.75 3.6–3.9 Effective Unconfirmed
hospitalizations
[23] 2006
Switzerland 2nd Community 3.4 2.40 Basic Unconfirmed deaths [24] 2009
United
Kingdom
2nd Community 3 1.39 1.36–1.43 Effective Unconfirmed deaths [33] 2008
United
Kingdom
2nd Community 6 1.84 1.75–1.92 Effective Unconfirmed deaths [33] 2008
United
Kingdom
2nd Community 6 1.55 Basic Unconfirmed illness [26] 2005
United
Kingdom
2nd Community 2.6 1.50 Basic Unconfirmed deaths [10] 2006
USA 2nd Community 2.5 2.14 Basic Unconfirmed deaths [34] 2009
USA 2nd Community NR 2.20 1.55–2.84 Effective Unconfirmed illness [35] 2007
USA 2nd Community 4 2.00 1.7–2.3 Effective Unconfirmed deaths [36] 2004
USA 2nd Community 2.85 1.73 Effective Unconfirmed deaths [14] 2007
United
Kingdom
3rd Community 3 1.39 1.29–1.49 Effective Unconfirmed deaths [33] 2008
United
Kingdom
3rd Community 6 1.82 1.61–2.05 Effective Unconfirmed deaths [33] 2008
United
Kingdom
3rd Community 6 1.70 Basic Unconfirmed illness [26] 2005
Median reproduction number for the 1918 pandemic: 1.80; Interquartile range 1.47–2.27
aThe first wave of illnesses began in the Northern Hemisphere in the spring 1918 [1]. A second wave of more intense transmission occurred concurrently in North
America, Europe, and Africa in the Fall of 1918 while a third and final wave of activity occurred in some areas of the world during the winter of 1919 [37].
bThe generation time (GT) or serial interval (SI) assumed in the reproduction number estimation.
cConfidence interval.
NR = Not reported.
This table is also available as a .csv file as Additional file 1.
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Fifty-seven studies reported 78 separate 2009 pan-
demic values of R (Table 4; Figure 4). The median point
estimate of R in the community setting for all waves of
illness was 1.46 (IQR: 1.30–1.70) while a higher median
R value (R = 1.96; IQR: 1.50–2.23) was reported in con-
fined settings, such as military or summer camps,
schools, and night clubs. The value of R was similar
across the two distinct waves of illness: the median value
of R was 1.47 (IQR: 1.31–1.71) for the first wave and
1.48 (IQR: 1.30–1.66) for the second wave (Table 4).
A majority of 2009 pandemic values for R were calcu-
lated for populations in North America (30%) and Asia







95% CIc Basic or
effective
Case definition Reference Year
published
Netherlands 2nd Community 3 1.39 Basic Unconfirmed deaths [38] 2010
United
Kingdom
2nd Community 2.6 1.70 Basic Unconfirmed deaths [10] 2006
United
Kingdom
2nd Community 3 1.5–1.6 Basic Unconfirmed illness [39] 2008
United
Kingdom
2nd Community 4 1.7–1.8 Basic Unconfirmed illness [39] 2008
United
Kingdom
2nd Community 4.1 1.50 Effective Unconfirmed illness [25] 2006
United
Kingdom
2nd Community NR 1.65 Basic Serology confirmed
infection
[26] 2005
USA 2nd Community 4 1.70 Basic Unconfirmed illness [40] 2004
Median reproduction number for the 1957 pandemic: 1.65; Interquartile range 1.53–1.70
aThe 1957 influenza A/H2N2 pandemic began in February 1957 in southern China and spread to Singapore and Hong Kong in April [1]. The virus was first isolated
in the United States in June 1957 and was associated with a mild first wave of illnesses [1,41]. The peak of the pandemic occurred during the second wave in the
Northern Hemisphere in October 1957 and was followed by a third wave in January 1958.
bThe generation time (GT) or serial interval (SI) assumed in the reproduction number estimation.
cConfidence interval.
NR = Not reported.
This table is also available as a .csv file as Additional file 2.







95% CIc Basic or
effective




1st Community 2.95 1.89 Basic Unconfirmed illness [42] 1986










1st Community 4.1 1.80 Effective Unconfirmed illness [25] 2006
United
Kingdom
2nd Community NR 1.85 Effective Serology confirmed infection [26] 2005





4 1.43 1.23–1.63 Effective Serology; laboratory confirmed
illness; unconfirmed illness
[43] 2010
Median reproduction number for the 1968 pandemic: 1.80; Interquartile range 1.56–1.85.
aThe 1968 influenza A/H3N2 pandemic began in Hong Kong in July 1968. Large single waves of illness were reported in the Northern Hemisphere between
September 1968 and April 1969 (with peaks occurring in December 1968–January 1969). Large single waves of illnesses were reported in the Southern
Hemisphere between June and September 1969. Some countries in the Northern Hemisphere, such as the United Kingdom, did not have an outbreak of H3N2
until the winter of 1969–70.
bThe generation time (GT) or serial interval (SI) assumed in the reproduction number estimation.
cConfidence interval.
NR = Not reported.
This table is also available as a .csv file as Additional file 3.
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95% CIc Basic or
effective
Case definition Reference Year
published
Mexico 0 Community 1.91 1.25 0.76–1.74 Basic Laboratory confirmed illness [44] 2011
Australia 1st Community 2.8 1.50 1.50–2.70 Effective Laboratory confirmed illness [45] 2010
Australia 1st Community 2.8 1.20 1.0–1.4 Effective Laboratory confirmed illness [45] 2010
Australia 1st Community 2.9 2.40 2.3–2.4 Effective Laboratory confirmed illness [46] 2009
Australia, rural 1st Community 2.9 1.28 1.26–1.30 Effective Laboratory confirmed illness [47] 2011
Australia, urban 1st Community 2.9 1.26 1.22–1.30 Effective Laboratory confirmed illness [47] 2011
Canada 1st Community 1.91 1.30 1.12–1.47 Basic Laboratory confirmed illness [48] 2010
Canada 1st Community 2.78 2.21 1.98–2.50 Basic Laboratory confirmed illness [49] 2012
Canada 1st Community 3.6 1.63 1.31–1.96 Basic Laboratory confirmed illness [48] 2010
Canada 1st Community 4.31 1.31 1.25–1.38 Basic Laboratory confirmed illness [50] 2010
Chile 1st Community 2.5 1.80 1.6–2.0 Effective Unconfirmed emergency room visits [51] 2010
Chile, central 1st Community 3 1.32 1.27–1.37 Effective Unconfirmed hospitalizations [52] 2012
Chile, northern 1st Community 3 1.19 1.13–1.24 Effective Unconfirmed hospitalizations [52] 2012
Chile, southern 1st Community 3 1.58 1.45–1.72 Effective Unconfirmed hospitalizations [52] 2012
China 1st Community 2.6 1.25 1.22–1.28 Effective Laboratory confirmed illness [53] 2012
China 1st Community 4.31 1.53 1.45–1.60 Basic Laboratory confirmed illness [54] 2012
China 1st Community NR 1.68 Basic Laboratory confirmed illness [55] 2011
Hong Kong 1st Community 3 1.70 1.6–1.8 Effective Laboratory confirmed illness [56] 2010
Hong Kong 1st Community 3.2 1.45 1.4–1.5 Effective Laboratory confirmed illness [57] 2010
Israel 1st Community 2.92 1.06 0.97–1.16 Effective Laboratory confirmed illness [58] 2011
Italy 1st Community 2.6 1.30 1.23–1.32 Effective Unconfirmed illness [59] 2012
Japan 1st School 1.9 2.30 2.0–2.6 Effective Laboratory confirmed illness [60] 2009
Japan 1st Community 2.7 1.28 1.23–1.33 Effective Laboratory confirmed illness [60] 2009
Mexico 1st Community 1.91 1.58 1.34–2.04 Basic Unconfirmed illness [61] 2009
Mexico 1st Community 1.96 1.42 Basic Unconfirmed illness [62] 2010
Mexico 1st Community 2.6 1.40 1.2–1.9 Basic Laboratory confirmed illness [61] 2009
Mexico 1st Community 2.6 1.22 1.05–1.60 Basic Laboratory confirmed illness [61] 2009
Mexico 1st Community 3 1.80 1.78–1.81 Effective Unconfirmed illness [63] 2011
Mexico 1st Community 3 1.43 1.29–1.57 Effective Laboratory confirmed illness [64] 2009
Mexico 1st Community 3.1 2.20 2.1–2.4 Effective Laboratory confirmed illness [65] 2009
Mexico 1st Community 3.5 2.30 2.1–2.5 Basic Laboratory confirmed illness [11] 2009
Mexico 1st Community 3.6 1.75 1.6–1.9 Basic Seeding from Mexico [66] 2009
Mexico 1st Community 4.1 3.10 2.9–3.5 Effective Laboratory confirmed illness [65] 2009
Mexico City 1st Community 3 1.72 Basic Laboratory confirmed illness [67] 2009
Morocco 1st Community 2.3 1.44 1.32–1.56 Basic Laboratory confirmed illness [68] 2012
Morocco 1st Community 2.7 1.40 1.34–1.48 Basic Laboratory confirmed illness [68] 2012
Netherlands 1st Community 3 0.50 Effective Laboratory confirmed illness [69] 2009
New Zealand 1st Community 2.7 1.25 1.07–1.47 Effective Laboratory confirmed illness [70] 2011
New Zealand 1st Community 2.8 1.96 1.80–2.15 Effective Laboratory confirmed illness [71] 2009
New Zealand 1st Community 2.8 1.55 1.16–1.86 Effective Laboratory confirmed illness;
unconfirmed illness
[72] 2010
North America 1st Community 2.7 1.3–2.1 Basic Laboratory confirmed illness [73] 2010
Peru 1st Community 2.8 1.37 1.33–1.41 Effective Laboratory confirmed illness [74] 2009
Peru 1st Community 3 1.30 1.3–1.3 Effective Unconfirmed illness [75] 2011
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Table 4 Reproduction numbers from the 2009 influenza A/H1N1 pandemic (Continued)
Peru, Lima 1st Community 3 1.70 1.6–1.7 Effective Unconfirmed illness [75] 2011
Singapore 1st Dance club 1.91 1.9–2.1 Basic Laboratory confirmed illness [76] 2010
Singapore 1st Military NR 1.91 1.50–2.36 Effective Laboratory confirmed and
unconfirmed illness
[77] 2010
South Africa 1st Community 2.3 1.43 1.38–1.49 Effective Laboratory confirmed illness [78] 2012
South Africa 1st Community 2.78 1.47 1.30–1.72 Effective Laboratory confirmed illness [78] 2012
South Africa 1st Community 2.78 1.42 1.20–1.71 Effective Laboratory confirmed illness [78] 2012
Southern
Hemisphere
1st Community 1.9 1.16–1.53 Effective Laboratory confirmed illness [79] 2010
Southern
Hemisphere
1st Community 2.60 1.33 1.28–1.45 Basic Laboratory confirmed and
unconfirmed illness
[80] 2011
Taiwan 1st Community 1.91 1.14 1.04–1.25 Effective Laboratory confirmed illness [81] 2011
Taiwan 1st Community NR 1.16 0.98–1.34 Effective Serology confirmed infection [82] 2011
Thailand 1st Community 1.9 1.78 1.67–1.89 Basic Laboratory confirmed illness [83] 2009
Thailand 1st Community 2.6 2.07 1.92–2.22 Basic Laboratory confirmed illness [83] 2009
United
Kingdom
1st School 2.2 1.33 1.11–1.56 Effective Laboratory confirmed illness [84] 2012
United
Kingdom
1st Community 2.5 1.44 1.27–1.63 Effective Laboratory confirmed illness [85] 2009
USA 1st Community 2.2 1.70 1.4–2.1 Basic Laboratory confirmed illness [86] 2009
USA 1st Community 2.6 2.20 1.4–2.5 Basic Laboratory confirmed illness [86] 2009
USA 1st School 2.7 3.30 3.0–3.6 Effective Unconfirmed illness [87] 2009
USA 1st Community 3.5 1.3–2.0 1.0–2.2 Basic Laboratory confirmed illness [11] 2009
USA 1st Camp
attendees
7 2.20 1.4–3.3 Effective Unconfirmed illness [88] 2011
Vietnam 1st Community 1.9 1.50 1.5–1.6 Basic Laboratory confirmed illness [89] 2010
Vietnam 1st Community 3.6 2.00 1.9–2.2 Basic Laboratory confirmed illness [89] 2010
worldwide 1st Community 2.67 1–2 Effective Laboratory confirmed illness [90] 2011
China 2nd Community 4 1.66 1.27–2.05 Effective confirmed hospitalizations [91] 2012
China 2nd Community 4.3 1.70 1.4–1.9 Effective Laboratory confirmed illness [92] 2010
France 2nd Military 2.9 1.5–1.6 Effective Unconfirmed illness [93] 2012
Iran 2nd school NR 1.28 1.05–1.54 Basic Unconfirmed illness [94] 2012
Italy 2nd Community 2.5 1.33 Effective Unconfirmed illness [95] 2011
Japan 2nd Community 3 1.48 1.41–1.56 Effective Unconfirmed illness [96] 2012
Mexico 2nd Community 3 1.62 1.61–1.63 Effective Unconfirmed illness [63] 2011
Reunion Island 2nd Community 2.8 1.26 1.08–1.49 Effective Unconfirmed illness [97] 2010
Taiwan 2nd Community 1.91 1.02 1.01–1.02 Effective Laboratory confirmed illness [81] 2011
Taiwan 2nd Community NR 1.87 1.68–2.06 Effective Serology confirmed infection [82] 2011
United
Kingdom
2nd Community 2.5 1.30 1.2–1.5 Effective Laboratory confirmed illness [98] 2010
Mexico 3rd Community 3 1.24 1.23–1.24 Effective Unconfirmed illness [63] 2011
various Community NR 1.30 1.1–1.4 Effective Serology confirmed infection [99] 2012
Median reproduction number for the 2009 pandemic: 1.46; Interquartile range 1.30–1.70
aThe 2009 influenza A/H1N1 pandemic began in Mexico in the late winter or early spring of 2009 [44]. The United States and the United Kingdom experienced a
first wave of illnesses in the Spring of 2009 followed by a second wave during the Fall of 2009 [4]. However, unlike these three countries, a number of countries,
especially in the Southern Hemisphere, only experienced a single wave of illnesses [100].
bThe generation time (GT) or serial interval (SI) assumed in the reproduction number estimation.
cConfidence interval.
NR = Not reported.
This table is also available as a .csv file as Additional file 4.
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95% CIb Basic or
effective




H3N8? USA & Europe 2.6 2.10 1.9–2.4 Basic Unconfirmed deaths [101] 2010
1948–
1949
H1N1 Canada 4.1 1.30 Effective Unconfirmed illness [25] 2006
1949–
1950
H1N1 Canada 4.1 1.50 Effective Unconfirmed illness [25] 2006
1950–
1951




























































































Brazil 3 1.03 1.02–1.04 Effective Unconfirmed deaths [111] 2010
1998–
1999
H3N2 Israel 3 1.14 Effective Unconfirmed illness [112] 2011
1998–
1999
H3N2 Israel 3 1.16 Effective Unconfirmed illness [112] 2011
1998–
1999







Israel 2.5 1.17–1.62 Effective Unconfirmed illness [114] 2012
1999–
2000
H3N2 Israel 3 1.16 Effective Unconfirmed illness [112] 2011
1999–
2000
H3N2 Israel 3 1.18 Effective Unconfirmed illness [112] 2011
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(26%). The mean generation time or serial interval used in
the calculations to determine R had a median value of
2.8 days, and the mean ranged from 1.9–7 days (Table 4).
A majority of the studies included for the 2009 pandemic
relied on either laboratory-confirmed illnesses (71%) or
unconfirmed illnesses (24%) to identify those ill (Table 4).
Seasonal influenza
Seasonal influenza causes sustained epidemics in the non-
tropical areas of the Northern Hemisphere and Southern
Hemisphere during their respective late fall to early spring
months. Epidemics in the tropical regions occur sporadically
but can be associated with the rainy season [1]. The

























Italy 4 1.17–1.36 Effective Unconfirmed illness [116] 2012
2001–
2002
H3N2 Israel 3 1.25 Effective Unconfirmed illness [112] 2011
2001–
2002
H3N2 Israel 3 1.27 Effective Unconfirmed illness [112] 2011
2003–
2004
H3N2 Israel 3 1.19 Effective Unconfirmed illness [112] 2011
2003–
2004
H3N2 Israel 3 1.21 Effective Unconfirmed illness [112] 2011
2003–
2004
H3N2 Switzerland 2.6 1.2–1.3 Effective Unconfirmed illness [117] 2011
2004–
2005
H3N2 Israel 3 1.25 Effective Unconfirmed illness [112] 2011
2004–
2005
H3N2 Israel 3 1.25 Effective Unconfirmed illness [112] 2011
2004–
2005
unspecified Taiwan 4.1 1.00 Effective Unconfirmed deaths [118] 2010
2004–
2005





H3N2 Israel 3 1.28 Effective Unconfirmed illness [112] 2011
2006–
2007
H3N2 Israel 3 1.33 Effective Unconfirmed illness [112] 2011
2007–
2008
H3N2 Israel 3 1.25 Effective Unconfirmed illness [112] 2011
2007–
2008
H3N2 Israel 3 1.29 Effective Unconfirmed illness [112] 2011
2011/12 H1N1 Mexico 3 1.20 Effective Laboratory confirmed
hospitalizations
[120] 2012
2011/12 H1N1 Mexico 3 1.20 Effective Laboratory confirmed
hospitalizations
[121] 2012
2011/12 H1N1 Mexico 4 1.30 Effective Laboratory confirmed
hospitalizations
[121] 2012
Median reproduction number for seasonal influenza: 1.28; Interquartile range 1.19–1.37
aThe generation time (GT) or serial interval (SI) assumed in the reproduction number estimation
bConfidence interval
NR = Not reported
This table is also available as a .csv file as Additional file 5.
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95% CIb Basic or
Effective
Case definition Reference Year
Published










H5N1 Indonesia 7 0.00 0–0 Effective Laboratory confirmed
illness
[119] 2008





H5N1 Indonesia 6 0.1–0.25 0–0.4 Effective Laboratory confirmed
illness
[124] 2012
2006 H5N1 Indonesia 9.5 1.14 0.61–2.14 Basic Laboratory confirmed
illness
[123] 2007
Median reproduction number for novel influenza outbreaks: 0.34; Interquartile range 0.05–0.98
aThe generation time (GT) or serial interval (SI) assumed in the reproduction number estimation.
NR = Not reported.
bConfidence interval.
This table is also available as a .csv file as Additional file 6.
Figure 2 Estimates of the reproduction number for the 1918 influenza A/H1N1 pandemic according to location, wave of illness,
setting, and the serial interval or generation time assumed in the estimation method. For individual studies, the single estimate or median
of multiple estimates is shown as a circle for basic reproduction numbers or a square for effective reproduction numbers, and the range or
confidence interval is denoted by brackets. Estimates of the reproduction number are color coded based on the generation time or serial interval
used in calculations: red (<3 days), blue (≥3 days), or black (not reported or not used).
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mortality burden from influenza varies by season, and from
1976–2007, estimates of annual influenza-associated deaths
in the United States from respiratory and circulatory causes
ranged from 3,000 to 49,000 [3].
Twenty-four studies reported 47 separate seasonal epi-
demic values of R (Table 5; Figure 5). The median point
estimate of R in the community setting for seasonal in-
fluenza was 1.27 (IQR: 1.19–1.37) while a higher median
R value (R = 16.9) was reported in a British boarding
school during the 1977–78 influenza season (Table 5). R
values for seasons where H3N2 (R = 1.25; IQR: 1.18–
1.27) or H1N1 (R = 1.25; IQR: 1.18–1.35) predominated
were equivalent (Table 5).
A majority of seasonal influenza values for R were cal-
culated for populations in Israel (35%), Europe (25%),
and North America (21%). The mean generation time or
serial interval used in the calculations to determine R
had a median value of 3.0 days, and the mean ranged
from 2.0–7.0 days (Table 5). A majority of the studies in-
cluded for seasonal influenza relied on unconfirmed ill-
nesses or deaths (79%); the reminder relied on either
laboratory-confirmed illnesses or hospitalizations or
serologically-confirmed infections (Table 5).
Human infections with non-human influenza viruses
Human infections with novel or non-human influenza
viruses (also known as zoonotic influenza viruses) are
rare but can result in a pandemic if sustained person-
to-person transmission occurs and the population has
little or no pre-existing population immunity to the
virus. Therefore, instances of infection with non-
human influenza viruses are investigated thoroughly to
assess the transmissibility of the virus. The largest
number of novel influenza cases at the time of this re-
view was from the ongoing influenza A/H5N1 out-
break centered in Southeast Asia and the Middle
Figure 3 Estimates of the reproduction number for the 1957 influenza A/H2N2 and the 1968 influenza A/H3N2 pandemics according
to location, wave of illness, setting, and the serial interval or generation time assumed in the estimation method. For individual studies,
the single estimate or median of multiple estimates is shown as a circle for basic reproduction numbers or a square for effective reproduction
numbers, and the range or confidence interval is denoted by brackets. Estimates of the reproduction number are color coded based on the
generation time or serial interval used in calculations: red (<3 days), blue (≥3 days), or black (not reported or not used).
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East. From January, 1, 2003 to February 15, 2013, 620
laboratory-confirmed cases have been reported to the
WHO, of which 367 have died [127]. Another large
outbreak of novel influenza occurred in 1976 in Fort
Dix, New Jersey, which was caused by an influenza
A/H1N1 virus similar to those found circulating in
swine [122].
Four studies estimated the values of R for the A/H5N1
and A/H1N1 outbreaks (Table 6). Four out of six esti-
mates (67%) of R were less than one, and the highest
R estimate (R = 1.2) was for the 1976 A/H1N1 out-
break in a New Jersey military camp (a confined setting)
(Table 6).
A majority of novel A virus R values were calculated for
populations in Southeast Asia (67%), indicative of where
the bulk of A/H5N1 bird-to-human transmission occurs.
The mean generation time or serial interval used in the
calculations to determine R had a median value of 7.0 days,
and the mean ranged from 1.9–9.5 days (Table 6). All
studies relied on either laboratory-confirmed illness or
serological-confirmed infection (Table 6).
Discussion
In this review, the median R values reported for the four
pandemics and seasonal influenza varied between 1.27–
1.8 while R values for novel influenza were generally
below 1. We found the highest median reproduction
number associated with the 1918 and the 1968 influenza
pandemics (both 1.8), followed by the 1957 pandemic
(1.65), the 2009 pandemic (1.46), seasonal influenza epi-
demics (1.27), and novel influenza outbreaks. A majority
of R values published were for either the 1918 pandemic
or the 2009 pandemic; the 1957 and 1968 pandemics
had the fewest published studies. Researchers calculated
values for R for a variety of locations and utilized many
Figure 4 Estimates of the reproduction number for the 2009 Influenza A/H1N1 pandemic according to location, wave of illness,
setting, and the serial interval or generation time assumed in the estimation method. For individual studies, the single estimate or median
of multiple estimates is shown as a circle for basic reproduction numbers or a square for effective reproduction numbers, and the range or
confidence interval is denoted by brackets. Estimates of the reproduction number are color coded based on the generation time or serial interval
used in calculations: red (<3 days), blue (≥3 days), or black (not reported or not used).
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different case definitions, ascertainment methods, and
assumptions about the generation time or serial interval.
The approximate basic reproductive numbers for some
common infectious diseases range from 12–18 for mea-
sles, 12–17 for pertussis, and 4–7 for mumps, polio, ru-
bella, and smallpox [12]. These values are much higher
than what has been reported for influenza, and most R
values reported in this review ranged from 1.0–2.0.
However, the overall clinical attack rate and peak daily
incidence of an outbreak, which measures the potential
burden on healthcare services and school and workplace
absenteeism, are very sensitive to changes in the value of
R within this range. Past research utilizing a number of
assumptions on the symptomatic ratio, contact patterns,
and seeding has estimated that the cumulative clinical
attack rates for a pandemic when R = 1.3 ranged from
15%–21% and increased to 34%–42% for R = 2.0 [10,11].
Similarly, the peak daily attack rate is 0.5% for R = 1.3
and 2.2% for R = 2.0 [10]. Therefore, with only an abso-
lute difference in R of 0.7, the clinical attack rates in
these studies more than doubled and the peak daily inci-
dence more than quadrupled.
Differences in the value of R within this range also
affect the evaluation of potential mitigation strategies (e.
g., school closures, vaccination, household isolation) for
influenza pandemics. Analysis of strategies to mitigate
an influenza pandemic have found that the effectiveness
of non-travel-related control policies, such as school clo-
sures, household quarantine, and vaccination, would de-
crease as the value of R increases from 1.0 to 2.0 [10].
The success of various vaccination strategies would also
be more likely for values of R < 1.7 [10,11]. Therefore,
the small variations in pandemic R estimates found in
this analysis can have important implications for the
overall impact and success of mitigation efforts for an in-
fluenza pandemic. This finding highlights the importance
Figure 5 Estimates of the reproduction number in the community for seasonal influenza epidemics according to location, wave of
illness, and the serial interval or generation time assumed in the estimation method. For individual studies, the single estimate or median
of multiple estimates is shown as a circle for basic reproduction numbers or a square for effective reproduction numbers, and the range or
confidence interval is denoted by brackets. Estimates of the reproduction number are color coded based on the generation time or serial interval
used in calculations: red (<3 days), blue (≥3 days), or black (not reported or not used).
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of making precise estimates of R early in a pandemic.
Further research should focus on refining methods that
allow for early, robust estimates of R.
The results of this analysis reinforce the idea that R is a
measure that captures the transmissibility of an influenza
virus in the population under study and is not an intrinsic
value. The inputs for its calculation can include the popu-
lation contact rate, the probability of infection per contact,
the duration of illness, and the percentage of the popula-
tion that is susceptible which is affected by the character-
istics of the population under study. Therefore, the
variations in the value for R for the same pandemic or sea-
sonal outbreak are expected and may be due to the under-
lying social and socio-demographic factors of the
population studied, public health interventions, and geo-
graphical or climatic factors of the location. These varia-
tions include the percentage of the source’s population
under 18 years old; differences in contact patterns be-
tween age groups, which vary by country [128,129]; and
differences in population susceptibility profiles, which var-
ied by age group for the 2009 pandemic [130]. Another
important factor that may contribute to the variation is
the season from which data used to estimate R is col-
lected. While the effect of weather on the transmissibility
of influenza has not been fully explored, some studies have
shown that the level of absolute humidity is inversely cor-
related with influenza transmissibility [131,132]. There-
fore, estimates of R should be interpreted in the context of
the population under study and the season in which data
was collected and direct comparisons of R between popu-
lations should be undertaken with caution.
Variations in the estimated values of R may also be
driven by changes in surveillance intensity in the same
country over time. If a country suddenly improves its
surveillance system in response to a pandemic and is
better able to identify cases, then the number of cases
being reported will increase, even though the actual
number of cases occurring will not have changed. This
increase in the reported number of cases may increase
the estimated R as the growth rate of the outbreak will
increase [86]. Conversely, the value of R could be artifi-
cially lowered if countries implement changes in surveil-
lance practices that result in a lower number of
identified cases, such as reducing screening recommen-
dations, or have their surveillance systems overwhelmed.
This effect was seen in the United States during the
2009 pandemic, when influenza testing for every case
became unfeasible and testing recommendations were
changed [4].
One of the more important methodological assump-
tions that can have a large impact on the estimated value
of R is the length of the serial interval or generation time
used during the estimation of R. Longer serial intervals
have previously been associated with higher estimates of
R when compared to estimates from the same dataset
using shorter serial intervals [9]. In this analysis, esti-
mates of R from the 1918, 1957, and 1968 pandemics
utilized higher serial interval values than were used for
the 2009 pandemic or for seasonal influenza. Addition-
ally, higher values of R from the 2009 pandemic often
were estimated using a generation time or serial interval
of 3 days or more (Figure 4). Therefore, the estimates of
R included in this analysis should be interpreted in the
context of the serial intervals or generation times used
in the estimation method. Like R, the values for the gen-
eration time or the serial interval can vary by the source
population. Therefore, researchers estimating the values
of R should strive to use standard estimates of the serial
interval or generation time for influenza or at least in-
clude common values in a sensitivity analysis. This will
help with the comparability of R values across studies
and may aid in the correct interpretation of R estimates.
An additional way in which estimates of R may be biased
up or down lies in the choice of estimation procedure it-
self. Chowell et al. showed that estimates of R obtained
using simple epidemic mathematical models varied con-
siderably as the model increased in complexity (e.g. the
addition of a period of infection latency or an age-
structured population) [35].
Although we found no difference in the value of R for
studies using confirmed cases versus unconfirmed cases
in the estimation method, the trade-off between the accur-
acy of the less specific but more efficient and cost effective
syndromic data compared to laboratory-confirmed influ-
enza infections is unknown. The incubation periods of
non-influenza respiratory pathogens that co-circulate with
influenza (e.g. respiratory syncytial virus or rhinovirus)
range from a median of 1.9–5.6 days; estimates of R for in-
fluenza could either be overestimated or underestimated
during periods of co-circulation, depending on the in-
tensity and identity of the co-circulating respiratory pa-
thogen [87]. Future research should focus on estimation
of R using laboratory-confirmed cases and hospitaliza-
tions and should provide estimates from syndromic data
for comparison.
Most studies included in this analysis focused on 1918
or the 2009 pandemic. Only a small number of estimates
of the reproduction number have been reported for the
two other pandemics of the 20th century (1957 and
1968). As a consequence, there is still insufficient infor-
mation to fully clarify the transmission dynamics of the
1957 and 1968 pandemics. Because historical data are
available for these pandemics, future research should
focus on estimations of R for the 1957 and 1968 pan-
demics to better understand the characteristics of these
pandemics.
This study generally found higher reproduction num-
bers for confined settings, such as schools, military
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bases, or night clubs, except for estimates from the 1968
pandemic. Because confined settings increase the inten-
sity of transmission by increasing contact rates among
those ill and well, the values of R presented for out-
breaks in confined settings are likely to be much higher
than values of R estimated for the community and
should be interpreted accordingly. While the estimation
of R in confined settings may be useful for the assess-
ment of the upper bounds of transmissibility, its value is
not directly comparable to estimates of R made in the
community setting.
This review found, with one exception, a high degree
of consistency in the estimated values of R for seasonal
influenza epidemics. The only notable exception was the
extremely high R values estimated for an outbreak of in-
fluenza A (H1N1) in 1978 at a small British boarding
school with 763 male students aged 10–18 who were
mostly full boarders [133]. The results of this analysis
suggest that the extreme R values reported for this out-
break are not typical of seasonal or pandemic influenza
and instead may be the result of the lack of pre-existing
immunity among the students to the strain of influenza
A (H1N1) that caused the outbreak, the extremely high
contact rates likely among a group of boarded students,
or a study artifact related to the small number of stu-
dents in the study population [13,106,133]. Additionally,
the median R value of seasonal influenza (R = 1.27) is
well below the median values seen during the four pan-
demics examined in this report. The consistency of sea-
sonal R values is even more remarkable given the wide
variety of estimation methods, data sources, and as-
sumptions used in the studies included here. However,
the majorities of seasonal influenza estimates were from
a small number of countries. Estimates of R from coun-
tries in Africa, Asia, and South America are also needed
to determine if values of R for seasonal influenza epi-
demics are affected by geographic and social factors.
This systematic review is subject to at least three limi-
tations. First, we combined estimates for the basic and
effective reproductive numbers when presenting the me-
dian estimates in this study. Even though these values
measure transmission in populations with differing levels
of underlying population immunity, some papers in-
cluded in this review did not clearly differentiate be-
tween basic and effective reproductive numbers or state
the required population immunity assumptions when
reporting basic reproductive numbers. Therefore, we
choose to present summary values for the basic and ef-
fective reproductive numbers together to simplify the re-
sults. The tables include whether the reproductive
number estimate was reported as basic or effective for
each study. Second, we did not assess included studies
for the type or quality of their methodology or the risk
of study bias. Finally, we only included published
estimates of the reproductive number, which may not be
representative of unpublished reproductive number
values.
Conclusions
In this review, we explored the ranges and uncertainty of
the values of R estimated for seasonal, pandemic, and
novel influenza. We found that values of R changed over
the course of a pandemic but the effect of the waves var-
ied. The value of R is not constant and may be affected
by mitigation strategies, the season, and the population
under study. The values of R found in this analysis rep-
resent the difference between a pandemic that is con-
trollable with less intensive mitigation strategies and
would cause moderate amounts of illness to a pandemic
that would require very intensive mitigation strategies
and would cause greater amounts of illness. Continued
monitoring of R during outbreaks of human infections
with non-human influenza viruses and in various set-
tings throughout future pandemics will be required to
fully understand the effects of mitigation, geography,
and season.
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